Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024 at 17:00 PM EDT
The study results on Leqembi, which Eisai shares with Biogen, also found that Alzheimer's patients who take the therapy get worse after they stop treatment.
